• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Warning Letter

Integra LifeSciences reveals FDA warning letter over chronic wound treatment

March 11, 2019 By Brad Perriello

Integra LifeSciences (NSDQ:IART) today revealed its receipt of a warning letter sent by the FDA last week about quality system issues at a Boston-area plant that makes products to treat chronic wounds. Plainsboro, N.J.-based Integra said the FDA inspected the plant last October and November, resulting in a Form 483 covering the problems found there. […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Integra LifeSciences, Warning Letter

FDA warns Medtronic on CRM plants in Minnesota, Puerto Rico

September 12, 2018 By Brad Perriello

The FDA this week released warning letters it sent to Medtronic (NYSE:MDT) over issues with cardiac rhythm management plants in Minnesota and Puerto Rico. The federal safety watchdog said inspections in April and May at both plants turned up problems related to the recall of CRM devices over high-voltage arcing, which led to the recall […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Medtronic, Warning Letter

FDA releases Zimmer Biomet warning letter

August 29, 2018 By Brad Perriello

The FDA yesterday released the warning letter it sent last week to Zimmer Biomet (NYSE:ZBH) over quality violations found during 2016 and 2018 inspections at a plant in Warsaw, Ind. Zimmer revealed its receipt of the August 24 letter earlier this week, saying it doesn’t expect to take a material hit from resolving the issues flagged in […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Warning Letter, Zimmer Biomet

Zimmer Biomet reveals FDA warning letter for Indiana plant

August 27, 2018 By Brad Perriello

Zimmer Biomet (NYSE:ZBH) today said it received a warning letter last week from the FDA about a plant in its home base of Warsaw, Ind., over quality violations found during a 2016 inspection. The FDA inspected the North Campus location in Warsaw just before Thanksgiving 2016, documenting numerous violations in a Form 483. The company’s lengthy […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: Warning Letter, Zimmer Biomet

FDA lifts Staar Surgical warning letter

June 20, 2018 By Brad Perriello

Staar Surgical (NSDQ:STAA) said today that the FDA lifted a 2014 warning letter issued over design and quality issues at a plant in California. Inspections by the federal safety watchdog that year turned up 15 issues at the plant in Monrovia where the company makes its intraocular lenses. The warning letter cited missing design files for […]

Filed Under: Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: STAAR Surgical Co, Warning Letter

FDA warns Magellan Diagnostics on lead tests

October 23, 2017 By Brad Perriello

The FDA today warned Meridian Bioscience (NSDQ:VIVO) subsidiary Magellan Diagnostics based on the Class I recall of its lead poisoning tests, accusing the company of failing to protect patients after it learned of problems with the tests. The May recall, which was expanded in July, involves Magellan’s LeadCare, LeadCare II, Ultra and Plus products. The tests may underestimate blood lead levels […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: magellandiagnostics, Warning Letter

FDA warns Entellus Medical over Xpress sinus dilator pediatric trial

September 6, 2017 By Brad Perriello

The FDA sent a warning letter to Entellus Medical (NSDQ:ENTL) over its failure to prevent physicians from violating the approved protocol for a pediatric trial of its Xpress sinus dilator. The April 6 letter, published online this week by the federal safety watchdog, stems from an inspection that began exactly a year ago of a […]

Filed Under: Clinical Trials, Wall Street Beat Tagged With: Ear Nose & Throat (ENT), Entellus Medical Inc., Warning Letter

FDA lifts warning letter on Zimmer Biomet plant in China

June 13, 2017 By Brad Perriello

Zimmer Biomet (NYSE:ZBH) said today that the FDA closed out a 2015 warning letter over problems at a subsidiary’s plant in China. The June 3, 2015 letter flagged 5 violations found during inspections of the Zhejiang Biomet Medical Products plant in Jinhua City, Zhejiang, following inspections of January of that year. The federal safety watchdog closed the matter […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Warning Letter, Zimmer Biomet

FDA lifts warning letter on Masimo plant in California

June 6, 2017 By Brad Perriello

Masimo (NSDQ:MASI) said today that the FDA lifted a 2014 warning letter issued over procedures at the Irvine, Calif., plant that makes its Pronto 7 pulse oximeters. The federal safety watchdog sent the letter in August 2014 after inspections in August to October 2013, flagging Masimo for failing to “review, evaluate, and investigate complaints involving the possible […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Masimo, Warning Letter

FDA warns Abbott on St. Jude Medical plant in California

April 13, 2017 By Brad Perriello

The FDA yesterday issued another warning letter about a St. Jude Medical (NYSE:STJ) plant in California, now owned by Abbott (NYSE:ABT), that makes cardiac rhythm management products. It’s at least the 2nd time the federal safety watchdog has flagged the plant in Sylmar, which makes defibrillators and the Merlin home cardiac monitor. In 2012 the FDA slapped St. […]

Filed Under: Food & Drug Administration (FDA), Wall Street Beat Tagged With: Abbott, Cardiac Rhythm Management, stjudemedical, Warning Letter

FDA sends warning letters to 12 medical device companies

August 17, 2016 By Brad Perriello

The FDA today published the warning letters it sent recently to 12 medical device companies in the U.S. and overseas for violations found during recent inspections. The federal safety watchdog’s inspectors found a variety of problems at the companies’ plants, ranging from inadequate design control procedures to problems with the way they track and report adverse […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: ARCOS, Aussimed, Beyond Technology, C World KSG, FP Rubinestein y Cia, Helica Instruments, Implants International, Master & Frank Enterprises, Mooncup, Novastep, Spiegelberg, W&R Investments (dba Laser Engineering), Warning Letter

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 16
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy